Filing Details
- Accession Number:
- 0001891015-21-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-03 19:38:57
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-11-03 19:38:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1372299 | Ocugen Inc. | OCGN | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1791821 | Uday Kompella | C/O Ocugen, Inc. 263 Great Valley Parkway Malvern PA 19355 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-11-01 | 25,000 | $14.05 | 179,416 | No | 4 | S | Indirect | By: Kompella LLC |
| Common Stock | Disposition | 2021-11-02 | 25,000 | $16.01 | 154,416 | No | 4 | S | Indirect | By: Kompella LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By: Kompella LLC |
| No | 4 | S | Indirect | By: Kompella LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 550,674 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Billionaire Hedge Funds
